Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,083 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mortality in diabetic patients with cardiovascular autonomic neuropathy.
Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Rathmann W, et al. Among authors: ziegler d. Diabet Med. 1993 Nov;10(9):820-4. doi: 10.1111/j.1464-5491.1993.tb00173.x. Diabet Med. 1993. PMID: 8281726
Effects of previous glycaemic control on the onset and magnitude of cognitive dysfunction during hypoglycaemia in type 1 (insulin-dependent) diabetic patients.
Ziegler D, Hübinger A, Mühlen H, Gries FA. Ziegler D, et al. Diabetologia. 1992 Sep;35(9):828-34. doi: 10.1007/BF00399928. Diabetologia. 1992. PMID: 1397777
Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy.
Ziegler D, Dannehl K, Mühlen H, Spüler M, Gries FA. Ziegler D, et al. Diabet Med. 1992 Nov;9(9):806-14. doi: 10.1111/j.1464-5491.1992.tb01898.x. Diabet Med. 1992. PMID: 1473320
Neurophysiological tests in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients with subclinical and symptomatic neuropathy.
Ziegler D, Mühlen H, Gries FA. Ziegler D, et al. Diabetologia. 1992 Nov;35(11):1099-100. doi: 10.1007/BF02221689. Diabetologia. 1992. PMID: 1473623 No abstract available.
Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients.
Ziegler D, Dannehl K, Wiefels K, Gries FA. Ziegler D, et al. Diabet Med. 1992 Aug-Sep;9(7):622-9. doi: 10.1111/j.1464-5491.1992.tb01857.x. Diabet Med. 1992. PMID: 1511568 Clinical Trial.
Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis and standard tests of heart-rate variation in newly diagnosed IDDM patients.
Ziegler D, Dannehl K, Volksw D, Mühlen H, Spüler M, Gries FA. Ziegler D, et al. Diabetes Care. 1992 Jul;15(7):908-11. doi: 10.2337/diacare.15.7.908. Diabetes Care. 1992. PMID: 1516513
The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group.
Ziegler D, Gries FA, Spüler M, Lessmann F. Ziegler D, et al. J Diabetes Complications. 1992 Jan-Mar;6(1):49-57. doi: 10.1016/1056-8727(92)90049-q. J Diabetes Complications. 1992. PMID: 1562759 Clinical Trial.
Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses.
Ziegler D, Laux G, Dannehl K, Spüler M, Mühlen H, Mayer P, Gries FA. Ziegler D, et al. Diabet Med. 1992 Mar;9(2):166-75. doi: 10.1111/j.1464-5491.1992.tb01754.x. Diabet Med. 1992. PMID: 1563252
[Treatment of pain in diabetic polyneuropathy].
Ziegler D, Gries FA. Ziegler D, et al. Dtsch Med Wochenschr. 1991 May 3;116(18):716-7. Dtsch Med Wochenschr. 1991. PMID: 1673922 German. No abstract available.
One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy.
Ziegler D, Mayer P, Rathmann W, Gries FA. Ziegler D, et al. Diabetes Res Clin Pract. 1991 Oct;14(1):63-73. doi: 10.1016/0168-8227(91)90054-h. Diabetes Res Clin Pract. 1991. PMID: 1748064 Clinical Trial.
1,083 results
Jump to page
Feedback